Published in Vaccine Weekly, April 18th, 2001
I.M. van der Lubben and colleagues proposed that chitosan microparticles offer a unique vehicle for vaccine delivery because they are small enough to be absorbed by Peyer's patches in mice and bioavailable enough to release...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.